Results 301 to 310 of about 59,693 (345)

Injectable Estradiol Dosing Regimens in Transgender and Nonbinary Adults Listed as Male at Birth. [PDF]

J Endocr Soc
Kanin M, Slack M, Patel R, Chen KT, Jackson N, Williams KC, Grock S.   +6 more
europepmc   +1 more source

Refractory hypokalaemia and hypertension in pregnancy in a woman with renal artery stenosis. [PDF]

Obstet Med
Phillips J, Iftikhar I, Sunanda G, Jeffs L.   +3 more
europepmc   +1 more source

The antihypertensive efficacy of a quadruple single-pill combination in patients with resistant hypertension: study protocol for a randomized, open-label, crossover trial. [PDF]

Trials
Yao Y, Zhang X, Ye R, Jia S, Yang X, Chen X.   +5 more
europepmc   +1 more source

Prescribing patterns for treatment of acne vulgaris: A retrospective chart review at an urban public and private hospital. [PDF]

Arch Dermatol Res
Syder NC, Hurtado ACM, Saizan A, Gonzalez M, Rodman J, Elbuluk N.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Polymorphism of Spironolactone

Journal of Pharmaceutical Sciences, 1991
Single crystals of two polymorphic and four solvated crystalline forms of spironolactone (C24H32O4S) were obtained using different solvents. The morphology, symmetry, and crystallographic parameters were determined for all crystal forms except for the one obtained from methanol.
B. Legendre, N. Rodier, J. M. Cense, Denis Wouessidjewe, Viatcheslav N. Agafonov   +4 more
openaire   +3 more sources

Tolerance of spironolactone

British Journal of Dermatology, 1988
A survey of 54 patients taking spironolactone for hirsutes or acne showed that side-effects occurred in 91%; in 80% of patients, these were related to the anti-androgenic mechanism of the drug (menstrual disturbances, and breast enlargement and tenderness).
Bronwyn R. Hughes, William J. Cunliffe
openaire   +2 more sources

The spironolactone renaissance

Expert Opinion on Investigational Drugs, 2001
Until recently, spironolactone was considered only as an antagonist at the aldosterone receptors of the epithelial cells of the kidney and was used clinically in the treatment of hyperaldosteronism and, occasionally, as a K(+)-sparing diuretic. The spironolactone renaissance started with the experimental finding that spironolactone reversed aldosterone-
Doggrell, Sheila A., Brown, Lindsay
openaire   +4 more sources

Readministration of Spironolactone in the Spironolactone-Intolerant Patient

Allergy and Asthma Proceedings, 1986
We report a successful practical protocol for readministration of spironolactone in a patient with cirrhosis and severe ascites whose initial exposure to spironolactone resulted in erythema multiforme. Because salt and water restriction and other diuretics were ineffective, readministration of spironolactone was considered appropriate.
Paul A. Greenberger, Harold P. Lazar
openaire   +3 more sources

Spironolactone for hypertension

Cochrane Database of Systematic Reviews, 2010
Spironolactone is an aldosterone antagonist, considered fourth line therapy for hypertension in patients already treated with multiple medications.Primary: to determine the effect of spironolactone on patient mortality, morbidity, and to quantify the magnitude of blood pressure lowering effect of spironolactone monotherapy.Secondary: to determine the ...
Josh Batterink, Aaron M Tejani, Sarah N Stabler, Curt T Fowkes   +3 more
openaire   +3 more sources